Search Result "HER2 Protein"
Anti-HER2 Cancer Therapy and Cardiotoxicity
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 4911-4919
Author(s): Tania Babar, Christopher Blomberg, Eileen Hoffner, Xinhua Yan
MicroRNA and HER2-overexpressing Cancer
Journal: MicroRNA
Volume: 2 Issue: 2 Year: 2013 Page: 137-147
Author(s): Shizhen E. Wang,Ren-Jang Lin
HER2-targeted Therapeutic Strategies for HER2-positive Metastatic Breast Cancers
Journal: Current Cancer Therapy Reviews
Volume: 10 Issue: 3 Year: 2014 Page: 225-233
Author(s): Teruhiko Fujii,Keisuke Miwa,Tomoyuki Ushijima,Mototsugu Matsunaga,Masaru Fukahori,Kotaro Yuge,Uhi Toh,Nobutaka Iwakuma,Ryuji Takahashi,Hiroki Takahashi,Miki Takenaka,Mai Mishima,Yoshito Akagi,Masayoshi Kage,Shino Nakagawa
HER2 Targeted Therapies for Cancer and the Gastrointestinal Tract
Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 537-542
Author(s): Noor Al-Dasooqi, Rachel Gibson, Joanne Bowen, Dorothy Keefe
Cytotoxicity of Sodium Arsenite-loaded Anti-HER2 Immunoliposomes Against HER2-expressing Human Breast Cancer Cell Lines
Journal: Letters in Drug Design & Discovery
Volume: 16 Issue: 5 Year: 2019 Page: 556-562
Author(s): Moslem Afrakhteh,Alireza Kheirollah,Aminollah Pourshohod,Mohammad Ali Ghaffari,Mostafa Jamalan,Majid Zeinali
Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 74-80
Author(s): Peng Liu,Hailin Tang,Jiali Wu,Xingsheng Qiu,Yanan Kong,Lijuan Zhang,Xinhua Xie,Xiangsheng Xiao
P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 4 Year: 2014 Page: 501-510
Author(s): S.M. Donnelly, E. Paplomata, B.M. Peake, E. Sanabria, Z. Chen, R. Nahta
HER2 Targeted Monoclonal Antibodies and Tyrosine Kinase Inhibitors
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 4 Year: 2014
Author(s): Neil A. O`Brien,Alexandra Canonici,Karen Howe,Martina S.J. McDermott,Denis M. Collins,Brigid C. Browne,John Crown,Norma O`Donovan
Doi: 10.2174/978160859225114040007
Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 17 Year: 2018 Page: 1976-1998
Author(s): Paula Gonzalez-Alonso,Ion Cristobal,Sandra Zazo,Ester Martin-Aparicio,Cristina Chamizo,Juan Madoz-Gurpide,Ana Rovira,Pilar Eroles,Ana Lluch,Joan Albanell,Federico Rojo
Nano-pharmaceutical Formulations for Targeted Drug Delivery against HER2 in Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 1 Year: 2015 Page: 71-86
Author(s): Sams M.A. Sadat,Soodabeh Saeidnia,Adil J. Nazarali,Azita Haddadi